M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases

Journal of Cellular Physiology

Volumn 232, Issue 12, 2017, Pages 3468-3480

  Vinnakota, Katyayni ^a   Zhang, Yuan ^a   Selvanesan, Benson Chellakkan ^a   Topi, Geriolda ^a   Salim, Tavga ^a   Sand Dejmek, Janna ^a   Jönsson, Gunilla ^a   Sjölander, Anita ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

colon cancer; epithelial mesenchymal transition; LTD4; M2 macrophages; MMPs; TNF ; tumor cell invasion; tumor associated macrophages

Indexed keywords

ADALIMUMAB; BETA CATENIN; COLLAGEN TYPE 1; GELATINASE; GELATINASE B; LEUKOTRIENE D4; MESSENGER RNA; MONTELUKAST; TRANSCRIPTION FACTOR SNAIL; TUMOR NECROSIS FACTOR; UVOMORULIN; VIMENTIN; CONDITIONED MEDIUM; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MATRIX METALLOPROTEINASE INHIBITOR; MMP9 PROTEIN, HUMAN;

ARTICLE; CANCER PATIENT; CANCER TISSUE; CELL INVASION; COLON BIOPSY; COLON CANCER; COLON CANCER CELL LINE; CONDITIONED MEDIUM; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY; TUMOR INVASION; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; COLONIC NEOPLASMS; DRUG EFFECTS; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; NUDE MOUSE; PARACRINE SIGNALING; PATHOLOGY; PHENOTYPE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; CULTURE MEDIA, CONDITIONED; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE D4; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PARACRINE COMMUNICATION; PHENOTYPE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR MICROENVIRONMENT; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 85012252427     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25808     Document Type: Article

References (45)

1. Aggarwal, B. B. (2003). Signalling pathways of the TNF superfamily: A double-edged sword. Nature Reviews. Immunology, 3(9), 745–756.
2. Benson, C. S., Babu, S. D., Radhakrishna, S., Selvamurugan, N., & Ravi Sankar, B. (2013). Expression of matrix metalloproteinases in human breast cancer tissues. Disease Markers, 34(6), 395–405.
3. Cammarota, R., Bertolini, V., Pennesi, G., Bucci, E. O., Gottardi, O., Garlanda, C., … Albini, A. (2010). The tumor microenvironment of colorectal cancer: Stromal TLR-4 expression as a potential prognostic marker. Journal of Translational Medicine, 8, 112. DOI: 10.1186/1479-5876-8-112
4. Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003). Regulation of matrix metalloproteinases: An overview. Molecular and Cellular Biochemistry, 253(1–2), 269–285.
5. Chen, H. N., Yuan, K., Xie, N., Wang, K., Huang, Z., Chen, Y., … Huang, C. (2016). PDLIM1 Stabilizes the E-Cadherin/beta-Catenin Complex to Prevent Epithelial-Mesenchymal Transition and Metastatic Potential of Colorectal Cancer Cells. Cancer Research, 76(5), 1122–1134.
6. Collins, H. M., Morris, T. M., & Watson, S. A. (2001). Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: Relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase. British Journal of Cancer, 84(12), 1664–1670.
7. Cox, T. R., & Erler, J. T. (2011). Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer. Disease Models & Mechanisms, 4(2), 165–178.
8. Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007). MAP kinase signalling pathways in cancer. Oncogene, 26(22), 3279–3290.
9. Edin, S., Wikberg, M. L., Dahlin, A. M., Rutegard, J., Oberg, A., Oldenborg, P. A., & Palmqvist, R. (2012). The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS ONE, 7(10), e47045.
10. Egberts, J. H., Cloosters, V., Noack, A., Schniewind, B., Thon, L., Klose, S., … Trauzold, A. (2008). Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Research, 68(5), 1443–1450.
11. Ekbom, A., Helmick, C., Zack, M., & Adami, H. O. (1990). Ulcerative colitis and colorectal cancer. A population-based study. New England Journal of Medicine, 323(18), 1228–1233.
12. Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., … Li, M. O. (2014). The cellular and molecular origin of tumor-associated macrophages. Science, 344(6186), 921–925.
13. Friedl, P., & Alexander, S. (2011). Cancer invasion and the microenvironment: Plasticity and reciprocity. Cell, 147(5), 992–1009.
14. Gutschalk, C. M., Yanamandra, A. K., Linde, N., Meides, A., Depner, S., & Mueller, M. M. (2013). GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression. Cancer Medicine, 2(2), 117–129.
15. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674.
16. Jiang, Y. G., Luo, Y., He, D. L., Li, X., Zhang, L. L., Peng, T., … Lin, Y. H. (2007). Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. International Journal of Urology, 14(11), 1034–1039.
17. Kong, D., Li, Y., Wang, Z., & Sarkar, F. H. (2011). Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: Are they cousins or twins? Cancers (Basel), 3(1), 716–729.
18. Lakka, S. S., Jasti, S. L., Gondi, C., Boyd, D., Chandrasekar, N., Dinh, D. H., … Rao, J. S. (2002). Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene, 21(36), 5601–5608.
19. Lameijer, M. A., Tang, J., Nahrendorf, M., Beelen, R. H., & Mulder, W. J. (2013). Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease. Expert Review of Molecular Diagnostics, 13(6), 567–580.
20. Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014). Chronic inflammation and cytokines in the tumor microenvironment. Journal of Immunology Research, 2014, 149185.
21. Lin, C. Y., Tsai, P. H., Kandaswami, C. C., Lee, P. P., Huang, C. J., Hwang, J. J., & Lee, M. T. (2011). Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Science, 102(4), 815–827.
22. Lorusso, G., & Ruegg, C. (2008). The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochemistry and Cell Biology, 130(6), 1091–1103.
23. Lu, P., Weaver, V. M., & Werb, Z. (2012). The extracellular matrix: A dynamic niche in cancer progression. The Journal of cell biology, 196(4), 395–406.
24. Magnusson, C., Mezhybovska, M., Lörinc, E., Fernebro, E., Nilbert, M., & Sjölander, A. (2010). Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer. European Journal of Cancer, 46(4), 826–835.
25. Mantovani, A., Schioppa, T., Porta, C., Allavena, P., & Sica, A. (2006). Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Reviews, 25(3), 315–322.
26. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., & Sica, A. (2002). Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology, 23(11), 549–555.
27. Mehdawi, M. L., Prasad, C. P., Ehrnström, R., Liu, Q., Andersson, T., & Sjölander, A. (2016). Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells. Molecular Oncology, 10(9), 1415–1429.
28. Mehlen, P., & Puisieux, A. (2006). Metastasis: A question of life or death. Nature Reviews. Cancer, 6(6), 449–458.
29. Mook, O. R., Frederiks, W. M., & Van Noorden, C. J. (2004). The role of gelatinases in colorectal cancer progression and metastasis. Biochimica et Biophysica Acta, 1705(2), 69–89.
30. Qian, B. Z., & Pollard, J. W. (2010). Macrophage diversity enhances tumor progression and metastasis. Cell, 141(1), 39–51.
31. Radisky, E. S., & Radisky, D. C. (2010). Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. Journal of Mammary Gland Biology and Neoplasia, 15(2), 201–212.
32. Ruffell, B., Affara, N. I., & Coussens, L. M. (2012). Differential macrophage programming in the tumor microenvironment. Trends in Immunology, 33(3), 119–126.
33. Salim, T., Sand-Dejmek, J., & Sjölander, A. (2014). The inflammatory mediator leukotriene D(4) induces subcellular beta-catenin translocation and migration of colon cancer cells. Experimental Cell Research, 321(2), 255–266.
34. Salim, T., Sjölander, A., & Sand-Dejmek, J. (2013). Nuclear expression of Glycogen synthase kinase-3beta and lack of membranous beta-catenin is correlated with poor survival in colon cancer. International Journal of Cancer Journal International du Cancer, 133(4), 807–815.
35. Samuelsson, B., Dahlen, S. E., Lindgren, J. A., Rouzer, C. A., & Serhan, C. N. (1987). Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science, 237(4819), 1171–1176.
36. Sanchez-Tillo, E., de Barrios, O., Siles, L., Cuatrecasas, M., Castells, A., & Postigo, A. (2011). Beta-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proceedings of the National Academy of Sciences of the United States of America, 108(48), 19204–19209.
37. Savari, S., Chandrashekar, N. K., Osman, J., Douglas, D., Bellamkonda, K., Jönsson, G., … Sjölander, A. (2016). Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model. Carcinogenesis, 37(5), 491–499.
38. Savari, S., Vinnakota, K., Zhang, Y., & Sjolander, A. (2014). Cysteinyl leukotrienes and their receptors: Bridging inflammation and colorectal cancer. World Journal of Gastroenterology, 20(4), 968–977.
39. Savari, S., Liu, M., Zhang, Y., Sime, W., & Sjölander, A. (2013). CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer. PLoS ONE, 8(9), e73466.
40. Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006). Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. European Journal of Cancer, 42(6), 717–727.
41. Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65(2), 87–108.
42. Tutton, M. G., George, M. L., Eccles, S. A., Burton, S., Swift, R. I., & Abulafi, A. M. (2003). Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients. International Journal of Cancer Journal International du Cancer, 107(4), 541–550.
43. Wang, H., Wang, H. S., Zhou, B. H., Li, C. L., Zhang, F., Wang, X. F., … Du, J. (2013). Epithelial-mesenchymal transition (EMT) induced by TNF-alpha requires AKT/GSK-3beta-mediated stabilization of snail in colorectal cancer. PLoS ONE, 8(2), e56664.
44. Zhang, Y., Sime, W., Juhas, M., & Sjölander, A. (2013). Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration. European Journal of Cancer, 49(15), 3320–3334.
45. Zucker, S., & Vacirca, J. (2004). Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Reviews, 23(1–2), 101–117.